Spermidine/spermine-N1-acetyltransferase: A key metabolic regulator

American Journal of Physiology - Endocrinology and Metabolism

Volumn 294, Issue 6, 2008, Pages

  Pegg, Anthony E ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Acetyl coenzyme A; Polyamines; Spermidine; Spermine

Indexed keywords

ACETYL COENZYME A; ACYLTRANSFERASE; ADENOSINE TRIPHOSPHATE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; S ADENOSYLMETHIONINE; SPERMIDINE; SPERMIDINE SPERMINE N1 ACETYLTRANSFERASE; SPERMINE; TOXIN; UNCLASSIFIED DRUG; DIAMINE ACETYLTRANSFERASE; DIAMINE N-ACETYLTRANSFERASE; MESSENGER RNA;

CARBOHYDRATE METABOLISM; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME STRUCTURE; GENE; HUMAN; LIPID METABOLISM; NONHUMAN; POLYAMINE METABOLISM; PRIORITY JOURNAL; REVIEW; SAT1 GENE; ACETYLATION; ANIMAL; BIOSYNTHESIS; CHEMICAL STRUCTURE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROTEIN SYNTHESIS;

ACETYL COENZYME A; ACETYLATION; ACETYLTRANSFERASES; ADENOSINE TRIPHOSPHATE; ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MODELS, MOLECULAR; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SPERMINE; TRANSCRIPTION, GENETIC;

EID: 47549106852     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.90217.2008     Document Type: Review

References (151)

1. Abo-Dalo B, Ndjonka D, Pinnen F, Liebau E, Luersen K. A novel member of the GCN5-related N-acetyltransferase superfamily from Caenorhabditis elegans preferentially catalyses the N-acetylation of thialysine [S-(2-aminoethyl)-L-cysteine]. Biochem J 384: 129-137, 2004.
2. Alhonen L, Parkkinen JJ, Keinänen T, Sinervirta R, Herzig KH, Jänne J. Activation of polyamine catabolism in transgenic rats induces acute pancreatitis. Proc Natl Acad Sci USA 97: 8290-8295, 2000.
3. Alhonen L, Räsänen TL, Sinervirta R, Parkkinen JJ, Korhonen VP, Pietilä M, Jänne J. Polyamines are required for the initiation of rat liver regeneration. Biochem J 362: 149-153, 2002.
4. 1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells. Mol Cancer Ther 6: 128-137, 2007.
5. 1-acetyltransferase in HeLa cells is regulated by amino acid sufficiency. Int J Biochem Cell Biol 35: 1388-1398, 2003.
6. Babbar N, Gerner EW. Polyamines as modifiers of genetic risk factors in human intestinal cancers. Biochem Soc Trans 31: 388-392, 2003.
7. 1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J 394: 317-324, 2006.
8. 1-acetyltransferase through nuclear factor κB in non-small cell lung cancer cells. J Biol Chem 281: 24182-24192, 2006.
9. Babbar N, Ignatenko NA, Casero RA Jr, Gerner EW. Cyclooxygenase-independent induction of apoptosis by sulindac sulfone is mediated by polyamines in colon cancer. J Biol Chem 278: 47762-47775, 2003.
10. 1-acetyltransferase-2 is an essential component of the ubiquitin ligase complex that regulates hypoxia-inducible factor 1α. J Biol Chem 282: 23572-23580, 2007.
11. 1-acetyltransferase-1 binds to hypoxia-inducible factor-1α (HIF-1α) and RACK1 and promotes ubiquitination and degradation of HIF-1α. J Biol Chem 282: 33358-33366, 2007.
12. Basuroy UK, Gerner EW. Emerging concepts in targeting the polyamine metabolic pathway in epithelial cancer chemoprevention and chemotherapy. J Biochem (Tokyo) 139: 27-33, 2006.
13. Beckers A, Organe S, Timmermans L, Scheys K, Peeters A, Brusselmans K, Verhoeven G, Swinnen JV. Chemical inhibition of acetyl-CoA carboxylase induces growth arrest and cytotoxicity selectively in cancer cells. Cancer Res 67: 8180-8187, 2007.
14. Bergeron RJ, Feng Y, Weimar WR, McManis JS, Dimova H, Porter C, Raisler B, Phanstiel O. A comparison of structure-activity relationships between spermidine and spermine analogue antineoplastics. J Med Chem 40: 1475-1494, 1997.
15. 1-acetyltransferase a potential therapeutic drug target. Proc Natl Acad Sci USA 103: 2063-2068, 2006.
16. Boncher T, Bi X, Varghese S, Casero RA Jr, Woster PM. Polyamine-based analogues as biochemical probes and potential therapeutics. Biochem Soc Trans 35: 356-363, 2007.
17. 1-acetyltransferase by CK1 and modulation of its binding to mitochondria: a comparison with CK2. Biochem Biophys Res Commun 290: 463-468, 2002.
18. 1-acetyltransferase mRNA translation. J Biol Chem 282: 28530-28539, 2007.
19. 1-acetyltransferase. J Biol Chem 266: 810-814, 1991.
20. 1- acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res 49: 3829-3833, 1989.
21. 1-acetyltransferase in a human large cell lung carcinoma. Biochem J 270: 615-620, 1990.
22. 1-acetyltransferase superinduced in response to treatment with antitumor polyamine analogues. Cancer Res 54: 3955-3958, 1994.
23. 1-acetyltransferase: the turning point in polyamine metabolism. FASEB J 7: 653-661, 1993.
24. Casero RA Jr, Frydman B, Stewart TM, Woster PM. Significance of targeting polyamine metabolism as an antineoplastic strategy: unique targets for polyamine analogues. Proc West Pharmacol Soc 48: 24-30, 2005.
25. Casero RA Jr, Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 6: 373-390, 2007.
26. Cason AL, Ikeguchi Y, Skinner C, Wood TC, Lubs HA, Martinez F, Simensen RJ, Stevenson RE, Pegg AE, Schwartz CE. X-linked spermine synthase gene (SMS) defect: the first polyamine deficiency syndrome. Eur J Hum Genet 11: 937-944, 2003.
27. 1-acetyltransferase in canine prostate epithelial cells. Biochem Biophys Res Commun 231: 383-388, 1997.
28. 1-acetyltransferase specifically binds to the integrin α9 subunit cytoplasmic domain and enhances cell migration. J Cell Biol 167: 161-170, 2004.
29. 1-acetyltransferase. Biochem J 373: 661-667, 2003.
30. 1-acetyltransferase expression, depletes polyamines, and synergistically induces apoptosis in colon carcinoma cells. J Biol Chem 280: 3295-3304, 2005.
31. 1-acetyltransferase. Mol Carcinog 45: 685-693, 2006.
32. 1-acetyltransferase in human cancer cells in response to increased production of reactive oxygen species. Biochem Pharmacol 55: 1119-1123, 1998.
33. 12-bis(ethyl)spermine. Biochemistry 34: 13423-13430, 1995.
34. 1-acetyltransferase. Biochem J 316: 697-701, 1996.
35. 1-acetyltransferase and prevent its targeting to the proteasome for degradation. Biochem J 358: 137-145, 2001.
36. 1-acetyltransferase requires the carboxyl-terminal glutamic acid residues. J Biol Chem 272: 12164-12169, 1997.
37. 1- acetyltransferase increases susceptibility to chemically-induced skin carcinogenesis. Carcinogenesis 23: 359-364, 2002.
38. 1-acetyltransferase-2 (SSAT2) acetylates thialysine and is not involved in polyamine metabolism. Biochem J 384: 139-148, 2004.
39. Cook T, Roos D, Morada M, Zhu G, Keithly JS, Feagin JE, Wu G, Yarlett N. Divergent polyamine metabolism in the Apicomplexa. Microbiology 153: 1123-1130, 2007.
40. deHart GW, McCloskey DE, Pegg AE, Sheppard D. The α9β1 integrin enhances cell migration by localizing polyamine catabolism and modulating inward-rectifier potassium channels. Proc Natl Acad Sci USA. In press.
41. 1-acetyltransferase. Biochem J 213: 701-706, 1983.
42. 1-acetyltransferase expression by cytokines and polyamines in human hepatocarcinoma cells (HepG2). J Cell Physiol 174: 125-134, 1998.
43. 11-diethylnorspermine to prevent suicidal behaviour. Med Hypotheses 67: 192, 2006.
44. Erwin BG, Persson L, Pegg AE. Differential inhibition of histone and polyamine acetylases by multisubstrate analogues. Biochemistry 23: 4250-4255, 1984.
45. 1-acetyltransferase - a gene uniquely regulated by polyamines and their analogs. Biochim Biophys Acta 1216: 255-264, 1993.
46. 1-acetyltransferase activity by novel spermine analogs. Mol Pharmacol 52: 69-74, 1997.
47. 1-acetyltransferase in MALME-3M human melanoma cells. J Biol Chem 268: 19118-19125, 1993.
48. 1-acetyltransferase gene expression. Biochemistry 35: 14436-14444, 1996.
49. 1-spermidine/spermine acetyltransferase. J Biol Chem 280: 40328-40336, 2005.
50. 11-diethylnorspermine. Cancer Chemother Pharmacol 54: 122-126, 2004.
51. 11-bis(ethyl)norspermine. Clin Cancer Res 55: 1638-1641, 1999.
52. Gerner EW, Meyskens FL Jr. Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 4: 781-792, 2004.
53. Gerner EW, Meyskens FL Jr, Goldschmid S, Lance P, Pelot D. Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention. Amino Acids 33: 189-195, 2007.
54. 1-acetyltransferase (SSAT) gene with putrescine accumulation in a patient with a Xp21.1p2212 duplication and keratosis follicularis spinulosa decalvans (KFSD). Hum Genet 111: 235-241, 2002.
55. 1-acetyltransferase gene expression during early pregnancy in the pig. Biol Reprod 59: 1251-1258, 1998.
56. Hacker A, Marton LJ, Sobolewski M, Casero RA Jr. In vitro and in vivo effects of the conformationally restricted polyamine analogue CGC-11047 on small cell and non-small cell lung cancer cells. Cancer Chemother Pharmacol. In press.
57. ε- acetyltransferase (HsSSAT2) in complex with acetyl coenzyme A. Proteins 64: 288-293, 2006.
58. Han L, Xu C, Guo Y, Li H, Jiang C, Zhao Y. Polyamine metabolism in rat myocardial ischemia-reperfusion injury. Int J Cardiol. In press.
59. 1-acetyltransferase. Mol Cancer Ther 3: 813-822, 2004.
60. 11 diethylnorspermine. Cancer Chemother Pharmacol. In press.
61. 1-acetyltransferase. Biochemistry 46: 7187-7195, 2007.
62. 1- acetyltransferase. Cell Biol Int 32: 39-47, 2008.
63. Holtta E, Sinervirta R, Janne J. Synthesis and accumulation of polyamines in rat liver regenerating after treatment with carbon tetrachloride. Biochem Biophys Res Commun 54: 350-357, 1973.
64. Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV, Sheppard D. Fatal bilateral chylothorax in mice lacking the integrin α9β1. Mol Cell Biol 20: 5208-5215, 2000.
65. Huang Y, Pledgie A, Casero RA Jr, Davidson NE. Molecular mechanisms of polyamine analogs in cancer cells. Anticancer Drugs 16: 229-241, 2005.
66. 1-acetyltransferase by interferon type I in cells of hematopoietic origin. J Interferon Cytokine Res 18: 337-344, 1998.
67. Husbeck B, Stringer DE, Gerner EW, Powis G. Increased thioredoxin-1 inhibits SSAT expression in MCF-7 human breast cancer cells. Biochem Biophys Res Commun 306: 469-475, 2003.
68. Hyvonen MT, Keinanen TA, Cerrada-Gimenez M, Sinervirta R, Grigorenko N, Khomutov AR, Vepsalainen J, Alhonen L, Janne J. Role of hypusinated eukaryotic translation initiation factor 5A in polyamine depletion-induced cytostasis. J Biol Chem 282: 34700-34706, 2007.
69. Hyvonen MT, Merentie M, Uimari A, Keinanen TA, Janne J, Alhonen L. Mechanisms of polyamine catabolism-induced acute pancreatitis. Biochem Soc Trans 35: 326-330, 2007.
70. 1-acetyltransferase. RNA 12: 1569-1582, 2006.
71. Ignatenko NA, Babbar N, Mehta D, Casero RA Jr, Gerner EW. Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells. Mol Carcinog 39: 91-102, 2004.
72. Ingi T, Worley PF, Lanahan AA. Regulation of SSAT expression by synaptic activity. Eur J Neurosci 13: 1459-1463, 2001.
73. Jänne J, Alhonen L, Pietilä M, Keinänen T. Genetic approaches to the cellular functions of polyamines in mammals. Eur J Biochem 271: 877-894, 2004.
74. Jänne J, Alhonen L, Pietila M, Keinanen TA, Uimari A, Hyvonen MT, Pirinen E, Jarvinen A. Genetic manipulation of polyamine catabolism in rodents. J Biochem (Tokyo) 139: 155-160, 2006.
75. 1-acetyltransferase affects fat metabolism in mice via acetyl-CoA. J Biol Chem 282: 8404-8413, 2007.
76. 11- diethylnorspermine alters the cellular localization of mTOR and downregulates mTOR protein level in glioblastoma cells. Cancer Biol Ther 6: 1644-1648, 2007.
77. 1-acetyltransferase elevates the threshold to pentylenetetrazol-induced seizure activity in transgenic mice. Exp Neurol 183: 645-652, 2003.
78. 1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment. Pharmacol Biochem Behav 78: 35-45, 2004.
79. Kee K, Foster BA, Merali S, Kramer DL, Hensen ML, Diegelman P, Kisiel N, Vujcic S, Mazurchuk RV, Porter CW. Activated polyamine catabolism depletes acetyl-CoA pools and suppresses prostate tumor growth in TRAMP mice. J Biol Chem 279: 40076-40083, 2004.
80. Kee K, Vujcic S, Merali S, Diegelman P, Kisiel N, Powell CT, Kramer DL, Porter CW. Metabolic and antiproliferative consequences of activated polyamine catabolism in LNCaP prostate carcinoma cells. J Biol Chem 279: 27050-27058, 2004.
81. Kim K, Ryu JH, Park JW, Kim MS, Chun YS. Induction of a SSAT isoform in response to hypoxia or iron deficiency and its protective effects on cell death. Biochem Biophys Res Commun 331: 78-85, 2005.
82. Kramer DL, Diegelman P, Jell J, Vujcic S, Merali S, Porter CW. Polyamine acetylation modulates polyamine metabolic flux - a prelude to broader metabolic consequences. J Biol Chem 283: 4241-4251, 2008.
83. + channels. J Gen Physiol 127: 467-480, 2006.
84. Libby PR. Calf liver nuclear N-acetyltransferases: purification and properties of two enzymes with both spermidine acetyltransferase and histone acetyltransferase activities. J Biol Chem 253: 233-237, 1978.
85. Liu B, Sutton A, Sternglanz R. A yeast polyamine acetyltransferase. J Biol Chem 280: 16659-16664, 2005.
86. 1-acetyltransferase. J Biol Chem 271: 18920-18924, 1996.
87. ε-acetyltransferase: identification of amino acid residues crucial for substrate binding. FEBS Lett 579: 5347-5352, 2005.
88. Marton LJ, Pegg AE. Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35: 55-91, 1995.
89. 12-bis(ethyl)spermine involves transcriptional and post-transcriptional regulation. Eur J Cancer 37: 281-289, 2001.
90. 1-acetyltransferase expression. Int J Biochem Cell Biol 36: 123-137, 2004.
91. 12-bis(ethyl)spermine and to cisplatin. Carcinogenesis 26: 1677-1685, 2005.
92. 1-acetyltransferase. Biochim Biophys Acta 675: 373-378, 1981.
93. Matsui I, Pegg AE. Increase in acetylation of spermidine in rat liver extracts brought about by treatment with carbon tetrachloride. Biochem Biophys Res Commun 92: 1009-1015, 1980.
94. Matsui I, Wiegand L, Pegg AE. Properties of spermidine N-acetyltransferase from livers of rats treated with carbon tetrachloride and its role in the conversion of spermidine into putrescine. J Biol Chem 256: 2454-2459, 1981.
95. 1-acetyltransferase stably expressed in Chinese hamster ovary cells. J Biol Chem 274: 6175-6182, 1999.
96. 1-acetyltransferase activity as a mechanism of cellular resistance to bis(ethyl)polyamine analogues. J Biol Chem 275: 28708-28714, 2000.
97. 11-bis(ethyl)norspermine. J Biol Chem 278: 13881-13887, 2003.
98. Merentie M, Uimari A, Pietila M, Sinervirta R, Keinanen TA, Vepsalainen J, Khomutov A, Grigorenko N, Herzig KH, Janne J, Alhonen L. Oxidative stress and inflammation in the pathogenesis of activated polyamine catabolism-induced acute pancreatitis. Amino Acids 33: 323-330, 2007.
99. 1-acetyltransferase and alternatively spliced mRNAs as a delayed response of HeLa S3 cells following X-ray irradiation. Int J Radiat Biol 80: 369-375, 2004.
100. 1-acetyltransferase activity in rat brain following transient focal cerebral ischemia and reperfusion. Neurosci Lett 300: 17-20, 2001.
101. Nairn LM, Lindsay GS, Woster PM, Wallace HM. Cytotoxicity of novel unsymetrically substituted inhibitors of polyamine biosynthesis in human cancer cells. J Cell Physiol 182: 209-213, 2000.
102. 1- acetyltransferase gene maintain nearly normal tissue polyamine homeostasis but show signs of insulin resistance upon aging. J Cell Mol Med 10: 933-945, 2006.
103. 1-acetyltransferase gene in mouse embryonic stem cells. Effects on polyamine homeostasis and sensitivity to polyamine analogues. J Biol Chem 277: 25323-25328, 2002.
104. 1-acetyltransferase mRNA in the human kidney cells infected by Venezuelan equine encephalitis and tick-borne encephalitis viruses. Virology 297: 163-171, 2002.
105. 12-bis(ethyl) spermine. Biochem J 305: 451-458, 1995.
106. Pegg AE. Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234: 249-262, 1986.
107. Pegg AE, Feith DJ, Fong LYY, Coleman CS, O'Brien TG, Shantz LM. Transgenic mouse models for studies of the role of polyamines in normal, hypertrophic and neoplastic growth. Biochem Soc Trans 31: 356-360, 2003.
108. Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol Cell Physiol 243: C212-C221, 1982.
109. 1-acetyltransferase using a specific antiserum. J Biol Chem 259: 12364-12367, 1984.
110. 1-acetyltransferase. J Invest Dermatol 116: 801-805, 2001.
111. Pirinen E, Kuulasmaa T, Pietila M, Heikkinen S, Tusa M, Itkonen P, Boman S, Skommer J, Virkamaki A, Hohtola E, Kettunen M, Fatrai S, Kansanen E, Koota S, Niiranen K, Parkkinen J, Levonen AL, Yla-Herttuala S, Hiltunen JK, Alhonen L, Smith U, Janne J, Laakso M. Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism. Mol Cell Biol 27: 4953-4967, 2007.
112. 2 in polyamine analogue-treated human breast cancer cell lines. J Biol Chem 280: 39843-39851, 2005.
113. Raina A, Janne J, Siimes M. Stimulation of polyamine synthesis in relation to nucleic acids in regenerating rat liver. Biochim Biophys Acta 123: 197-201, 1966.
114. Räsänen TL, Alhonen L, Sinervirta R, Keinänen T, Herzig KH, Suppola S, Khomutov AR, Vepsäläinen J, Jänne J. A polyamine analogue prevents acute pancreatitis and restores early liver regeneration in transgenic rats with activated polyamine catabolism. J Biol Chem 277: 39867-39872, 2002.
115. 1-acetyltransferase. Scand J Gastroenterol 38: 787-793, 2003.
116. 1-acetyltransferase during peri-implantation. Biol Reprod 65: 587-594, 2001.
117. Roussi S, Gosse F, Aoude-Werner D, Zhang X, Geoffroy P, Miesch M, Marchioni E, Raul F. Perturbation of polyamine metabolism and its relation to cell death in human colon cancer cells treated by 7β-hydroxycholesterol and 7β-hydroxysitosterol. Int J Oncol 29: 1549-1554, 2006.
118. Ryu JH, Cho YS, Chun YS, Park JW. Myocardial SSAT induction via AMPK signaling and its implication for ischemic injury. Biochem Biophys Res Commun 366: 438-444, 2008.
119. Sequeira A, Gwadry FG, Ffrench-Mullen JM, Canetti L, Gingras Y, Casero RA Jr, Rouleau G, Benkelfat C, Turecki G. Implication of SSAT by gene expression and genetic variation in suicide and major depression. Arch Gen Psychiatry 63: 35-48, 2006.
120. 1-acetyltransferase by intracellular polyamine pools. FEBS Lett 321: 179-183, 1993.
121. 1- acetyltransferase. Nucleosides Nucleotides Nucleic Acids 26: 1245-1248, 2007.
122. Soler AP, Gilliard G, Megosh LC, O'Brien TG. Modulations of murine hair follicle function by alterations in ornithine decarboxylase activity. J Invest Dermatol 106: 1108-1113, 1996.
123. Stachurska A, Dudkowska M, Czopek A, Manteuffel-Cymborowska M, Grzelakowska-Sztabert B. Cisplatin up-regulates the in vivo biosynthesis and degradation of renal polyamines and c-Myc expression. Biochim Biophys Acta 1689: 259-266, 2004.
124. 1-dansylnorspermine as the substrate. Anal Biochem. In press.
125. 1- acetyltransferase. Cancer Res 65: 5390-5398, 2005.
126. Ulrich S, Loitsch SM, Rau O, von Knethen A, Brune B, Schubert-Zsilavecz M, Stein JM. Peroxisome proliferator-activated receptor γ as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Res 66: 7348-7354, 2006.
127. Vlahakis NE, Young BA, Atakilit A, Hawkridge AE, Issaka RB, Boudreau N, Sheppard D. Integrin α9β1 directly binds to vascular endothelial growth factor (VEGF)-A and contributes to VEGF-A-induced angiogenesis. J Biol Chem 282: 15187-15196, 2007.
128. 1-acetyltransferase 2 (SSAT2) functions as a coactivator for NF-κB and cooperates with CBP and P/CAF to enhance NF-κB-dependent transcription. Biochim Biophys Acta 1759: 470-477, 2006.
129. Vujcic S, Diegelman P, Bacchi CJ, Kramer DL, Porter CW. Indentification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin. Biochem J 367: 665-675, 2002.
130. 1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem 275: 38319-38328, 2000.
131. Wallace HM, Duthie J, Evans DM, Lamond S, Nicoll KM, Heys SD. Alterations in polyamine catabolic enzymes in human breast cancer tissue. Clin Cancer Res 6: 3657-3661, 2000.
132. Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J 376: 1-14, 2003.
133. Wallace HM, Niiranen K. Polyamine analogues - an update. Amino Acids: 261-265, 2007.
134. 1-acetyltransferase activity increases susceptibility to skin carcinogenesis. Carcinogenesis 287: 2404-2411, 2007.
135. Wang Y, Casero RA Jr. Mammalian polyamine catabolism: a therapeutic target, a pathological problem, or both? J Biochem (Tokyo) 139: 17-25, 2006.
136. 1-acetyltransferase (SSAT) gene. Biochem J 355: 45-49, 2001.
137. 1-acetyltransferase gene. J Biol Chem 274: 22095-22101, 1999.
138. Wang Y, Murray-Stewart T, Devereux W, Hacker A, Frydman B, Woster PM, Casero RA Jr. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem Biophys Res Commun 304: 605-611, 2003.
139. 1-acetyltransferase gene transcription. J Biol Chem 273: 34623-34630, 1998.
140. Webb HK, Wu Z, Sirisoma N, Ha HC, Casero RA Jr, Woster PM. 1-(N-alkylamino)-11-(N-ethylamino)-4,8-diazaundecanes: simple synthetic polyamine analogues that differentially alter tubulin polymerization. J Med Chem 42: 1415-1421, 1999.
141. Woolridge DP, Martinez JD, Stringer DE, Gerner EW. Characterization of a novel spermidine/spermine acetyltransferase, BltD, from Bacillus subtilis. Biochem J 340: 753-758, 1999.
142. 1-acetylated polyamine oxidase by an acetylenic amine and the allenic amine, MDL 72527. Biochem Biophys Res Commun 326: 483-490, 2005.
143. 1-acetyltransferase (SSAT) gene in human lung carcinoma cells. Biochem J 313: 691-696, 1996.
144. 1- acetyltransferase gene. Biochem Biophys Res Commun 187: 1493-1502, 1992.
145. 1-acetyltransferase. Biochem Biophys Res Commun 179: 407-415, 1991.
146. 1- acetyltransferase exhibits different characteristics from the host enzyme. Mol Biochem Parasitol 152: 170-180, 2007.
147. 1- acetyltransferase overexpression in kidney epithelial cells disrupts polyamine homeostasis, leads to DNA damage, and causes G2 arrest. Am J Physiol Cell Physiol 292: C1204-C1215, 2007.
148. Zahedi K, Wang Z, Barone S, Prada AE, Kelly CN, Casero RA, Yokota N, Porter CW, Rabb H, Soleimani M. Expression of SSAT, a novel biomarker of tubular cell damage, increases in kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 284: F1046-F1055, 2003.
149. Zarember KA, Malech HL. HIF-1α: a master regulator of innate host defenses? J Clin Invest 115: 1702-1704, 2005.
150. Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 38: 769-789, 2006.
151. 1-acetyltransferase mRNA levels show marked and region-specific changes in the early phase after transient forebrain ischemia. Brain Res 38: 122-134, 1996.